Deceptive Marketing

Resource

CSPI and Rudd Center FDA Request for Enforcement re: Toddler Milks and Transition Formulas

February 9, 2021
Enfagrow's "premium toddler transitions" product.

Resource

CSPI comment on July 29, 2020 Citizen Petition

February 9, 2021
Nutramigen "toddler" formula
Article

FDA Urged to Stop Formula Companies from Selling Sugary Drinks as “Formula” to Toddlers

“Transition Formulas” and “Toddler Milks” Violate FDA Labeling Rules and Are Not Recommended by Experts
February 9, 2021
Gerber's "Good Start" transition formula product
Article

FDA and FTC Urged to Bring Enforcement Proceedings Against Joseph Mercola for False COVID-19 Health Claims

CSPI to Testify on COVID Scams in Senate Commerce Committee Today
July 21, 2020

Resource

Letters re: Request for Enforcement Regarding False COVID-19 Claims by Mercola Group

July 20, 2020
Article

CSPI Urges FDA Enforcement Action on Televangelist Jim Bakker’s Fake Coronavirus “Cure”

Letter Submitted to FDA and FTC
February 20, 2020

Resource

CSPI letter to FDA and FTC re Bakker

February 20, 2020

Resource

Ginkgo Biloba Lawsuit: Plaintiff’s Opening Appellate Brief

December 16, 2019
Article

Manufacturers of “Fertility” Supplements Selling False Hope

CSPI Asks the FDA and FTC to Take Enforcement Action
November 15, 2019
Three brands of "fertility support" supplements

Resource

Appendix to Letters re: Fertility Supplements

November 15, 2019
Three brands of "fertility support" supplements